Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 1/20 | 0.37 |
| ▸ | EPHX1 | P07099 | 4/20 | 0.32 |
| ▸ | CA12 | O43570 | 2/20 | 0.31 |
| ▸ | CA1 | P00915 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | MMP2 | P08253 | 2/20 | 0.31 |
| ▸ | CA9 | Q16790 | 2/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6303768 | 0.85 | SHBG (0.41) | SHBGEPHX1CA12CA1CA2 | |
| SCHEMBL1524833 | 0.83 | SHBG (0.39) | SHBGEPHX1TP53 | |
| SCHEMBL9204420 | 0.81 | SHBG (0.43) | SHBGEPHX1 | |
| SCHEMBL3421946 | 0.79 | SHBG (0.41) | SHBGEPHX1 | |
| SCHEMBL9213061 | 0.79 | SHBG (0.41) | SHBGEPHX1 | |
| SCHEMBL11677493 | 0.79 | SHBG (0.41) | SHBGEPHX1 | |
| SCHEMBL4490677 | 0.79 | SHBG (0.41) | SHBGEPHX1 | |
| SCHEMBL11085237 | 0.79 | SHBG (0.41) | SHBGEPHX1 | |
| SCHEMBL4723686 | 0.79 | SHBG (0.41) | SHBGEPHX1 | |
| SCHEMBL18098111 | 0.79 | SHBG (0.37) | SHBGEPHX1CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0971904-A1 | NOVEL 1-AMINO-3 BENZYL URACILS | BASF AKTIENGESELLSCHAFT (DE) | 2000-01-19 | — | — | EP | disclosed |
| WO-1998042682-A1 | NOVEL 1-AMINO-3 BENZYL URACILS | BASF AKTIENGESELLSCHAFT (DE) | 1998-10-01 | — | — | WO | disclosed |